Bromide

Bromide

SCHEMBL5088293

CCCCCCCCCC[N+](CC)(CC)CCCCCCCCCC.[Br-]

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 6/20 0.89
ALDH1A1 P00352 1/20 0.82
TP53 P04637 1/20 0.82
CYP3A4 P08684 1/20 0.82
ALOX15 P16050 1/20 0.82
TSHR P16473 1/20 0.82
ALOX12 P18054 1/20 0.82
SMN1; SMN2 Q16637 1/20 0.82
HIF1A Q16665 1/20 0.82
HSD17B10 Q99714 1/20 0.82
SLC22A1 O15245 3/20 0.77
SLC22A2 O15244 1/20 0.71
HSP90AA1 P07900 1/20 0.59
RAD52 P43351 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL5092506 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL11820808 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL5086749 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL6827078 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL5087088 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL5091560 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL2299537 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL5085169 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL5088585 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15
Bromide SCHEMBL5088331 1.00 DNM1 (0.89) DNM1ALDH1A1TP53CYP3A4ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119280450-A Medical fabric dressing with long-acting disinfection and sterilization functions and preparation method thereof 孙国明 2025-01-10 CN claimed
CN-118844836-A Long-acting disinfection and sterilization wet (towel) paper 孙国明 2024-10-29 CN claimed
CN-118844448-A Preparation method of long-acting antibacterial liquid 孙国明 2024-10-29 CN claimed
CN-116349679-A Composite disinfection and sterilization method 孙国明 2023-06-30 CN claimed
CN-115433376-A Preparation method of long-acting disinfection and sterilization fabric or fiber 孙国明 2022-12-06 CN claimed
US-20180316064-A1 Additive for Increasing Lifespan of Rechargeable Zinc-Anode Batteries RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW NEW YORK (US) 2018-11-01 US claimed
US-20260088352-A1 Heterocyclic Electrolyte Additives for Rechargeable Metal Batteries U S ARMY DEVCOM ARMY RES LABORATORY (US) 2026-03-26 US disclosed
CN-119280450-A Medical fabric dressing with long-acting disinfection and sterilization functions and preparation method thereof 孙国明 2025-01-10 CN disclosed
CN-118844448-A Preparation method of long-acting antibacterial liquid 孙国明 2024-10-29 CN disclosed
CN-118844836-A Long-acting disinfection and sterilization wet (towel) paper 孙国明 2024-10-29 CN disclosed
CN-117361516-A Degradable graphene dispersing agent and preparation method and application thereof 辽宁大学 2024-01-09 CN disclosed
WO-2023141689-A1 LONG-LASTING ANTIMICROBIAL COMPOSITIONS CONTAINING CATIONIC ACTIVE AGENTS AND ANIONIC EXCIPIENTS AND USES UNIVERSIDADE FEDERAL DE MINAS GERAIS - UFMG (BR) 2023-08-03 WO disclosed
US-20230223595-A1 Heterocyclic Electrolyte Additives for Rechargeable Metal Batteries THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE ARMY 2023-07-13 US disclosed
CN-116349679-A Composite disinfection and sterilization method 孙国明 2023-06-30 CN disclosed
CN-115433376-A Preparation method of long-acting disinfection and sterilization fabric or fiber 孙国明 2022-12-06 CN disclosed
US-10910674-B2 Additive for increasing lifespan of rechargeable zinc-anode batteries RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW NEW YORK (US) 2021-02-02 US disclosed
US-20180316064-A1 Additive for Increasing Lifespan of Rechargeable Zinc-Anode Batteries RESEARCH FOUNDATION OF THE CITY UNIVERSITY OF NEW NEW YORK (US) 2018-11-01 US disclosed
US-20080214386-A1 Stability; easily separated from solution; surface treatment of catalyst with Group seven compound; reacting epoxide with carbon dioxide NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2008-09-04 US disclosed
EP-0523158-A1 FUNGICIDAL PREPARATIONS NOVO NORDISK A/S (DK) 1993-01-20 EP disclosed
WO-1991015120-A1 FUNGICIDAL PREPARATIONS NOVO NORDISK A/S (DK) 1991-10-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088352-A1 Heterocyclic Electrolyte Additives for Rechargeable Metal Batteries CA3, CA1, HCN1 DNM1 1569/4885ALDH1A1 785/4885TP53 970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.